Farber

FLOTEK WELCOMES EVAN FARBER TO BOARD OF DIRECTORS

Retrieved on: 
Thursday, October 13, 2022
D.C, U.S. Securities and Exchange Commission, Securities Act of 1933, State University of New York, New, Private law, SEC, NYSE, General counsel, Research, Security (finance), Judgement, George Washington University Law School, Multimedia, Technology, Sustainability Accounting Standards Board, Hogan, Binghamton University, Board, Water, Securities Exchange Act of 1934, State university system, Farber, Director, Board of directors, Atmosphere, FTK, The Advisory Board Company, Solution, Risk, Renewable energy, Social, Kate Richard

HOUSTON, Oct. 13, 2022 /PRNewswire/ --On October 11, 2022, the Board of Directors (the "Board") of Flotek Industries, Inc. ("Flotek") (NYSE: FTK), a leader in technology-driven specialty green chemistry solutions, increased the number of directors on the Board from six to seven and appointed Evan Farber to the Board.

Key Points: 
  • HOUSTON, Oct. 13, 2022 /PRNewswire/ --On October 11, 2022, the Board of Directors (the "Board") of Flotek Industries, Inc. ("Flotek") (NYSE: FTK), a leader in technology-driven specialty green chemistry solutions, increased the number of directors on the Board from six to seven and appointed Evan Farber to the Board.
  • Mr. Farber was appointed as a member of the compensation and corporate governance and nominating committees of the Board.
  • Mr. Farber also serves on the Emeritus Board of the Children's Law Center, a non-profit legal services provider in Washington, D.C. Mr. Farber received a B.A.
  • John W. Gibson, Jr., Chairman, President, and Chief Executive Officer of Flotek said "We are excited to welcome Evan to our Board of Directors.

Creators' Legal Takes Flight: First-ever Legal Platform For the Creator Economy

Retrieved on: 
Wednesday, September 22, 2021
Social media, Intelligence, Founder CEO, Special creation, VC, Lakeshore Entertainment, Smartphone, Farber, Forbes, Lawyer, Sony Pictures, Sport, Amazon, Warner Bros., Faculty, Athlete, Dropbox (service), Senior, CEO, Program, LLC, Culture, WarnerMedia, History, Contract, General counsel, Creator's Bill of Rights, Music

Creators' Legal offers a multitude of specific contracts, all of which have been drafted by experienced content and media lawyers, as well as the tools content creators need to keep up with the ever-changing creator landscape.  Deals can be papered, executed and stored in a digital briefcase in minutes for a completely affordable price -- be it a one-off or yearly subscription.

Key Points: 
  • "Never before in history has it been easier to be a content creator," said Farber.
  • What has not kept pace is the affordability and ease in which content creators can protect their rights and interests.
  • Creators' Legal was co-founded by Phil Alberstat, a long-time entertainment lawyer, industry executive and author of the Content Creators' Handbook.
  • Virginia Longmuir, former General Counsel at Rat Pac Entertainment, LLC and legal counsel at Lakeshore Entertainment, serves as Senior Vice President at Creators' Legal.

Hahn & Hahn's Laura Farber and Jason Lyon Recognized as Legal Visionaries

Retrieved on: 
Tuesday, August 31, 2021
Employment, Farber, Judgement, Fraud, ABA, Council, Business, Leadership, Publishing, Latham & Watkins, Private Securities Litigation Reform Act, Crime, Ida, Countess von Hahn-Hahn, Trust, Hahn, Organization, Daily Journal Corporation, Lawyer, California, Lawsuit, Insurance, Property management

PASADENA, Calif., Aug. 31, 2021 /PRNewswire/ -- Southern California based law firm Hahn & Hahn announced today that Firm Partners Laura Farber and D. Jason Lyon have been recognized as visionaries in Business of Law: Trends, Updates & Visionaries, a special feature published this week by L.A. Times B2B Publishing.

Key Points: 
  • PASADENA, Calif., Aug. 31, 2021 /PRNewswire/ -- Southern California based law firm Hahn & Hahn announced today that Firm Partners Laura Farber and D. Jason Lyon have been recognized as visionaries in Business of Law: Trends, Updates & Visionaries, a special feature published this week by L.A. Times B2B Publishing.
  • Lawyerswere recognized as visionaries "for their contribution and leadership within their firms, the legal profession and the community at large," the feature says.
  • Lyon, recently named a 'Top Litigator' by the Los Angeles Business Journal, is also a litigation partner at Hahn & Hahn LLP.
  • "Prior to joining Hahn & Hahn, Lyon was an associate with Latham & Watkins, practicing in the Complex Commercial Litigation and Securities Litigation groups.

Valvoline Instant Oil Change Supports Cancer Research and Care at Dana-Farber Cancer Institute

Retrieved on: 
Tuesday, July 20, 2021
Dana–Farber Cancer Institute, Harvard Medical School, The Jimmy Fund, Farber, Valvoline, Dàna, Companies, Health care, Medicine

"We are excited to participate in this program once again this year," said Don Smith, CEO of Henley Enterprises, Inc, the largest franchisee of Valvoline Instant Oil Change .

Key Points: 
  • "We are excited to participate in this program once again this year," said Don Smith, CEO of Henley Enterprises, Inc, the largest franchisee of Valvoline Instant Oil Change .
  • "The Jimmy Fund has long been a pillar in our community, and the work they do to support cancer research and care at Dana-Farber Cancer Institute is remarkable."
  • To date, Henley Enterprises, has raised more than $297,00 for this program which helps fund imperative research and patient care at Dana-Farber Cancer Institute.
  • 2 chain by number of stores in the United States under the Valvoline Instant Oil ChangeSM brand.

AccessHope and Dana-Farber Cancer Institute Announce Foundational Partnership, Extending Access to Cancer Expertise Across the United States

Retrieved on: 
Tuesday, June 29, 2021
Research, Hospitals, Practice Management, Other Health, Managed care, Health, Other Science, Science, Oncology, Harvard Medical School, Medicine, Dana–Farber Cancer Institute, Health care, Health, Farber, Cancer, Sidney Farber, National Comprehensive Cancer Network, AccessHope, Dana-Farber Cancer Institute, ACCESSHOPE, DANA-FARBER CANCER INSTITUTE

AccessHope, LLC , a company that provides cancer expertise to employers and their health care partners, today announced a new foundational partnership with Dana-Farber Cancer Institute, extending member access to specialized cancer expertise to more people living with complex cancers across the United States.

Key Points: 
  • AccessHope, LLC , a company that provides cancer expertise to employers and their health care partners, today announced a new foundational partnership with Dana-Farber Cancer Institute, extending member access to specialized cancer expertise to more people living with complex cancers across the United States.
  • Through an employer benefit, employees of AccessHope clients have access to AccessHopes network of oncology experts.
  • Dana-Farber Cancer Institute blends leading science and exceptional care into transformative medicine and is a principal teaching affiliate of Harvard Medical School.
  • We provide the latest in cancer care for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center .

Dana-Farber Cancer Institute Livestreamed Campaign Announcement Event Powered by Brightcove Video Platform

Retrieved on: 
Tuesday, May 18, 2021
Music, Technology, Health, Philanthropy, Entertainment, Oncology, Other Philanthropy, Other Technology, Fund Raising, Audio, Video, Foundation, Farber, Dana–Farber Cancer Institute, The Jimmy Fund, Dàna, Health care, Medicine, Health

b'An adult nursing student from Trinidad, a talented young singer, a real estate developer, and a legendary journalist and author are all cancer survivors and were featured in Dana-Farber Cancer Institute\xe2\x80\x99s special online event last night, \xe2\x80\x9cThe Dana-Farber Campaign.

Key Points: 
  • b'An adult nursing student from Trinidad, a talented young singer, a real estate developer, and a legendary journalist and author are all cancer survivors and were featured in Dana-Farber Cancer Institute\xe2\x80\x99s special online event last night, \xe2\x80\x9cThe Dana-Farber Campaign.
  • Defy Cancer .\xe2\x80\x9d Tom Brokaw acted as storyteller for the virtual event that featured vignettes illustrating the strategic priorities to be supported by The Dana-Farber Campaign and its vision for preventing, treating, and Defying Cancer.
  • \xe2\x80\x9cThis event was critical to launch our ambitious, multi-year fundraising campaign," said Erin McVeigh, assistant vice president, Donor Relations at Dana-Farber Cancer Institute and the Jimmy Fund.
  • "We wanted a partner to video live stream our event.

Dana-Farber Cancer Institute Announces $2 Billion Fundraising Campaign to Defy Cancer

Retrieved on: 
Tuesday, May 18, 2021
Research, Entertainment, Philanthropy, Other Health, Celebrity, Fund Raising, Health, Other Philanthropy, Science, Oncology, Dana–Farber Cancer Institute, Harvard Medical School, Farber, Dàna, Health care, Oncology, Healthcare in the United States

b"Dana-Farber Cancer Institute today announced the most ambitious fundraising campaign in its history, and the largest campaign ever in New England focused entirely on cancer.

Key Points: 
  • b"Dana-Farber Cancer Institute today announced the most ambitious fundraising campaign in its history, and the largest campaign ever in New England focused entirely on cancer.
  • The Dana-Farber Campaign is a multi-year fundraising effort to raise $2 billion to accelerate the Institute\xe2\x80\x99s strategic priorities by supporting revolutionary science, extraordinary care, and exceptional expertise.\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210517005966/en/\nMore than 1,000 people joined Dana-Farber for a special one-hour virtual event on Monday night to kick off the campaign and embraced the Institute\xe2\x80\x99s vision to prevent, treat, and Defy Cancer.
  • We provide the latest in cancer care for adults through Dana-Farber/Brigham and Women's Cancer Center and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center .

Hale Family to Accelerate Pancreatic Cancer Research and Care with One of the Largest Single Gifts Ever to Dana-Farber Cancer Institute

Retrieved on: 
Tuesday, May 11, 2021
Science, Health, Oncology, Research, Farber, Dana–Farber Cancer Institute, Cancer, Hale, Cinema of the United States

b'Continuing their family\xe2\x80\x99s deep commitment to conquering pancreatic cancer, Judith B. Hale, her son, Robert T. Hale, Jr., and his wife, Karen Hale, have pledged an additional $50 million to Dana-Farber Cancer Institute.

Key Points: 
  • b'Continuing their family\xe2\x80\x99s deep commitment to conquering pancreatic cancer, Judith B. Hale, her son, Robert T. Hale, Jr., and his wife, Karen Hale, have pledged an additional $50 million to Dana-Farber Cancer Institute.
  • View the full release here: https://www.businesswire.com/news/home/20210511006101/en/\nDana-Farber donors, Karen Hale, her husband Robert T. Hale, Jr. , and his mother Judith B. Hale.
  • We share the Hale Family\xe2\x80\x99s bold vision to eradicate pancreatic cancer and save lives, here and around the world.
  • Longtime supporters of the Institute, Robert Sr. and Judith Hale established the Robert T. Hale Sr. and Judith B. Hale Fund for Pancreatic Cancer Research at Dana-Farber in 2007.\nThe Hale Family\xe2\x80\x99s commitment to research and care has continued across the generations.

Stop & Shop Raises Record-Breaking $3.1 Million During Its Annual ‘Help Cure Childhood Cancer’ Campaign

Retrieved on: 
Wednesday, May 5, 2021
Dana–Farber Cancer Institute, Harvard Medical School, Memorial Sloan Kettering Cancer Center, MSK, Farber, Health care, Hospitals, Medicine

b"QUINCY, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Stop & Shop today announced that its annual \xe2\x80\x98Help Cure Childhood Cancer\xe2\x80\x99 campaign raised a record-breaking $3.1 million for pediatric cancer research and care at Memorial Sloan Kettering Cancer Center (MSK) and Dana-Farber Cancer Institute.

Key Points: 
  • b"QUINCY, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Stop & Shop today announced that its annual \xe2\x80\x98Help Cure Childhood Cancer\xe2\x80\x99 campaign raised a record-breaking $3.1 million for pediatric cancer research and care at Memorial Sloan Kettering Cancer Center (MSK) and Dana-Farber Cancer Institute.
  • Donations made north of New Haven in Connecticut, and across Massachusetts and Rhode Island, were directed to the Dana-Farber Cancer Institute.
  • 100% of all donations benefitted the two hospitals, both leaders in the fight against pediatric cancer worldwide.\n\xe2\x80\x9cStop & Shop has generous and caring customers, and the results of this year\xe2\x80\x99s Help Cure Childhood Cancer campaign are evidence of that,\xe2\x80\x9d shared Gordon Reid, President of Stop & Shop.
  • MSK is home to more than 20,000 physicians, scientists, nurses and staff united by a relentless dedication to conquering cancer.

Aceragen Launches with Acquisition of Enzyvant‘s Investigational Therapy for Farber Disease and $35 Million Product Financing with NovaQuest

Retrieved on: 
Monday, May 3, 2021
Biotechnology, Pharmaceutical, Health, Other Health, Drug discovery, Pharmaceutical industry, Preclinical development, Farber, Farber disease and Acid Ceramidase Deficiency, Aceragen, NovaQuest Capital Management, Enzyvant, FARBER DISEASE AND ACID CERAMIDASE DEFICIENCY, ACERAGEN, NOVAQUEST CAPITAL MANAGEMENT, ENZYVANT

Enzyvant will receive an upfront payment and development and sales-based milestones up to $226 million, as well as tiered royalties on net sales.

Key Points: 
  • Enzyvant will receive an upfront payment and development and sales-based milestones up to $226 million, as well as tiered royalties on net sales.
  • Preclinical development for rhAC has been completed, including in vivo proof of concept in a mouse model of Farber disease, and IND-enabling GLP toxicology studies.
  • Patients with the most rapidly progressive form of Farber disease usually do not live beyond the first few years of life.
  • Enzyvant\xe2\x80\x99s lead asset is the investigational tissue-based regenerative therapy, RVT-802, for congenital athymia, an ultra-rare and life-threatening pediatric immunodeficiency.